A single dose of CKLF1 administered 1 h prior to ischemia can exacerbate nerve damage and the inflammatory response, suggesting that CKLF1 can be used to immunologically train microglia and then rapidly activate microglia in the presence of subsequent ischemic injury [25, 26]. This evidence concerns the gene CKLF and ischemia.